Abstract
The Royal Pharmaceutical Society (RPS) has said it maintains its support for leaving up to 12 weeks between administering doses of COVID-19 vaccines, despite pressure from some quarters to reduce the gap. The British Medical Association (BMA) has called for “a dialogue” with the government over halving the maximum interval between doses of the Pfizer/BioNTech […]
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
